封面
市場調查報告書
商品編碼
2151578

美國胃腸外科手術市場規模、佔有率和趨勢分析報告:按 CPT 代碼、適應症、手術緊急程度、最終用途和細分市場預測(2026-2033 年)

U.S. Gastrointestinal Surgery Procedures Market Size, Share & Trends Analysis Report By CPT, By Indication, By Procedure Urgency, By End Use, And Segment Forecasts, 2026 - 2033

出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

美國胃腸外科手術市場概述

預計到 2025 年,美國胃腸外科手術市場價值將達到 189 億美元,到 2026 年將成長至 195 億美元,到 2033 年將擴大至 244 億美元,2026 年至 2033 年的年複合成長率(CAGR)為 3.2%。

胃腸道疾病帶來的巨大且持續的負擔推動了這個市場的發展,進而產生了對外科診斷和治療的巨大需求。

大腸直腸癌、發炎性腸道疾病、憩室病、膽囊疾病以及肥胖相關的消化器官系統併發症等併發症疾病,導致醫院和門診手術中心的手術需求不斷成長。大腸直腸癌仍然是胃腸外科手術需求的主要促進因素。根據美國疾病管制與預防中心(CDC)的最新數據,2023年美國報告了155,662例新增大腸癌病例,2024年將有54,468人死於大腸癌。這種持續的疾病負擔支撐了對切除術、腸切除術術、直腸手術、膽囊切除術和其他腹部手術的需求。肥胖症盛行率的不斷上升是另一個重要的促進因素,尤其是在減重手術和代謝性胃腸手術方面。

根據美國疾病管制與預防中心(CDC)的數據,2021年8月至2023年8月期間,美國成年人肥胖率為40.3%。此外,2024年的一項監測調查顯示,美國各州和地區的成年人肥胖率至少為25%。肥胖不僅增加了符合減重手術條件的患者數量,還與多種可能需要胃腸道和腹部手術的疾病有關。因此,肥胖的持續流行預計將支撐袖狀切除術和胃繞道手術等手術的需求,同時也增加相關胃腸道和肝膽疾病的手術治療需求。

微創和機器人輔助手術的興起進一步推動了市場成長。腹腔鏡和機器人手術因其切口更小、視野更清晰、器械操作更便捷,且與傳統開放性手術相比術後恢復可能更快,正日益被應用於結直腸手術、減肥手術、膽囊手術和其他腹部手術中。對機器人手術平台的持續投資進一步強化了這一趨勢。例如,2026年7月21日,美國食品藥物管理局(FDA)批准了強生醫療科技公司(Johnson & Johnson MedTech)的OTTAVA機器人手術系統上市,為美國外科市場增添了一個新的機器人平台。因此,先進的機器人和腹腔鏡技術的日益普及,正在拓展醫院和外科醫生的技術選擇,並推動微創胃腸手術的發展。

此外,政府支持的結直腸癌篩檢透過促進大腸直腸疾病的早期發現和治療,間接支持了胃腸外科生態系統的發展。美國醫療保健和醫療服務中心 (CMS) 繼續將結直腸癌篩檢(包括篩檢大腸鏡檢查和其他經批准的篩檢測試)納入聯邦醫療保險 (Medicare) 的預防性服務範圍。早期發現大腸直腸異常有助於進一步的診斷評估,如果確診為癌症或晚期疾病,則需進行手術治療。這建構了從篩檢和診斷到手術治療的完整路徑,從而支撐了美國對結直腸手術的持續需求。

目錄

第1章:調查方法和範圍

第2章執行摘要

第3章:美國胃腸外科市場:變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 美國胃腸外科市場分析工具

第4章:美國胃腸外科市場:按臨床手術技術 (CPT) 分類的估算和趨勢分析

  • 美國胃腸外科市場:CPT(臨床專業技術)趨勢分析
  • 美國胃腸外科手術市場:按臨床手術技術 (CPT) 分類的展望
  • 2021年至2033年市場規模、預測與趨勢分析(涵蓋以下):
  • 43020-43135,43279-43499
  • 44005-44346、44500-44799、44800-44899、44900-44979、45000-45190、45395-45999、46020-46505、46990-46
  • 47010-47399、47400-47480、47562-47999、48020、48105-48160、48500-48999
  • 43644-43645、43770-43775、43845-43848、43886-43888

第5章:美國胃腸外科手術市場:按適應症分類的估算與趨勢分析

  • 美國胃腸外科手術市場:按適應症分類的趨勢分析
  • 美國胃腸外科手術市場:依適應症與前景分類
  • 2021年至2033年市場規模、預測與趨勢分析(涵蓋以下):
  • 癌症
  • 良性胃腸道疾病
  • 急診/急診
  • 肥胖
  • 其他疾病

第6章:美國胃腸外科手術市場:依手術緊急程度分類的估算與趨勢分析

  • 美國胃腸外科手術市場:依手術緊急程度分類的趨勢分析
  • 美國胃腸外科手術市場:依手術緊急程度分類的展望
  • 2021年至2033年市場規模、預測與趨勢分析(涵蓋以下):
  • 選擇性
  • 半緊急
  • 緊急狀況

第7章:美國胃腸外科手術市場:依最終用途分類的估算與趨勢分析

  • 美國胃腸外科手術市場:按最終用途分類的趨勢分析
  • 美國胃腸外科手術市場:按最終用途分類的展望
  • 2021年至2033年市場規模、預測與趨勢分析(針對以下產業)
  • 醫院
  • 門診手術中心
  • 專業外科中心
  • 其他

第8章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • Johnson & Johnson MedTech/Ethicon
    • Medtronic
    • Stryker
    • Intuitive Surgical
    • CONMED
    • Applied Medical
    • B. Braun
    • Teleflex
    • Olympus
    • KARL STORZ
    • BD
    • Cook Medical
    • WL Gore & Associates
    • Integra LifeSciences
    • Zimmer Biomet
Product Code: GVR-4-68041-029-5

U.S. Gastrointestinal Surgery Procedures Market Summary

The U.S. gastrointestinal surgery procedures market size was valued at USD 18.9 billion in 2025 and is projected to grow from USD 19.5 billion in 2026 to USD 24.4 billion by 2033, at a CAGR of 3.2% from 2026 to 2033. The market is supported by the large and continuing burden of digestive diseases, which creates a substantial need for surgical diagnosis and treatment.

Gastrointestinal conditions such as colorectal cancer, inflammatory bowel disease, diverticular disease, gallbladder disorders, and obesity-related digestive complications contribute to the demand for procedures across hospitals and ambulatory surgical centers. Colorectal cancer remains an important contributor to gastrointestinal surgical demand; according to the latest CDC data, 155,662 new colorectal cancer cases were reported in the U.S. in 2023, while 54,468 people died from colorectal cancer in 2024. The continued disease burden supports demand for procedures such as colectomy, bowel resection, rectal surgery, cholecystectomy, and other abdominal surgeries. The increasing prevalence of obesity is another important driver, particularly for bariatric and metabolic gastrointestinal procedures.

CDC data show that 40.3% of U.S. adults had obesity during August 2021-August 2023, while 2024 surveillance found that every U.S. state and territory had an adult obesity prevalence of at least 25%. The high obesity burden increases the patient population eligible for surgical weight-management procedures and is also associated with several conditions that can require gastrointestinal or abdominal surgery. As a result, the continued prevalence of obesity is expected to support demand for procedures such as sleeve gastrectomy and gastric bypass, while also increasing the need for surgical management of related gastrointestinal and hepatobiliary conditions.

The shift toward minimally invasive and robotic-assisted surgery is further strengthening market growth. Laparoscopic and robotic approaches are increasingly used for colorectal, bariatric, gallbladder, and other abdominal procedures because they can provide smaller incisions, improved visualization, greater instrument control, and potentially faster recovery compared with conventional open surgery. This trend is being reinforced by continued investment in robotic surgical platforms. For example, the FDA granted De Novo authorization for Johnson & Johnson MedTech's OTTAVA Robotic Surgical System on July 21, 2026, adding another robotic platform to the U.S. surgical market. The increasing availability of advanced robotic and laparoscopic technologies is therefore expanding technology options for hospitals and surgeons and supporting the transition toward minimally invasive gastrointestinal procedures.

Government-supported colorectal cancer screening is also indirectly supporting the gastrointestinal surgery ecosystem by encouraging earlier detection and treatment of colorectal disease. CMS continues to cover colorectal cancer screening as a Medicare preventive service, including screening colonoscopy and other approved screening tests. Earlier identification of colorectal abnormalities can lead to additional diagnostic evaluation and, when cancer or advanced disease is identified, surgical treatment. This creates a pathway from screening and diagnosis to surgical management, supporting continued demand for colorectal procedures in the U.S.

U.S. Gastrointestinal Surgery Procedures Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. gastrointestinal surgery procedures market report based on CPT, indication, procedure urgency, and end use:

  • CPT Outlook (Revenue, USD Billion, 2021 - 2033)
    • 43020-43135, 43279-43499
    • 44005-44346, 44500-44799, 44800-44899, 44900-44979, 45000-45190, 45395-45999, 46020-46505, 46700-46999
    • 47010-47399, 47400-47480, 47562-47999, 48020, 48105-48160, 48500-48999
    • 43644-43645; 43770-43775; 43845-43848; 43886-43888
  • Indication Outlook (Revenue, USD Billion, 2021 - 2033)
    • Cancer
    • Benign GI Disorders
    • Acute/Emergency Conditions
    • Obesity
    • Other Conditions
  • Procedure Urgency Outlook (Revenue, USD Billion, 2021 - 2033)
    • Elective
    • Urgent
    • Emergency
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Surgical Centers
    • Other

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. CPT
    • 1.2.2. Indication
    • 1.2.3. Procedure Urgency
    • 1.2.4. End Use
    • 1.2.5. Country scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. CPT Outlook
    • 2.2.2. Indication Outlook
    • 2.2.3. Procedure Urgency Outlook
    • 2.2.4. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Gastrointestinal Surgery Procedures Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Gastrointestinal Surgery Procedures Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. U.S. Gastrointestinal Surgery Procedures Market: CPT Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Gastrointestinal Surgery Procedures Market: CPT Movement Analysis
  • 4.3. U.S. Gastrointestinal Surgery Procedures Market by CPT Outlook (USD Billion)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 4.5. 43020-43135, 43279-43499
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6. 44005-44346, 44500-44799, 44800-44899, 44900-44979, 45000-45190, 45395-45999, 46020-46505, 46700-46999
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.7. 47010-47399, 47400-47480, 47562-47999, 48020, 48105-48160, 48500-48999
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.8. 43644-43645; 43770-43775; 43845-43848; 43886-43888
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. U.S. Gastrointestinal Surgery Procedures Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Gastrointestinal Surgery Procedures Market: Indication Movement Analysis
  • 5.3. U.S. Gastrointestinal Surgery Procedures Market by Indication Outlook (USD Billion)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 5.5. Cancer
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.6. Benign GI Disorders
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.7. Acute/Emergency Conditions
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.8. Obesity
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.9. Other Conditions
    • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Gastrointestinal Surgery Procedures Market: Procedure Urgency Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Gastrointestinal Surgery Procedures Market: Procedure Urgency Movement Analysis
  • 6.3. U.S. Gastrointestinal Surgery Procedures Market by Procedure Urgency Outlook (USD Billion)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 6.5. Elective
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.6. Urgent
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.7. Emergency
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. U.S. Gastrointestinal Surgery Procedures Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Gastrointestinal Surgery Procedures Market: End Use Movement Analysis
  • 7.3. U.S. Gastrointestinal Surgery Procedures Market by End Use Outlook (USD Billion)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 7.5. Hospitals
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.6. Ambulatory Surgical Centers
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7. Specialty Surgical Centers
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.8. Other
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Johnson & Johnson MedTech / Ethicon
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product/Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Medtronic
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product/Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Stryker
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product/Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Intuitive Surgical
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product/Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. CONMED
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product/Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Applied Medical
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product/Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. B. Braun
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product/Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Teleflex
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product/Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Olympus
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product/Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. KARL STORZ
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product/Service Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. BD
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product/Service Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Cook Medical
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product/Service Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. W. L. Gore & Associates
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Product/Service Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Integra LifeSciences
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Product/Service Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Zimmer Biomet
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Product/Service Benchmarking
      • 8.2.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. Gastrointestinal Surgery Procedures Market, by CPT, 2021 - 2033 (USD Billion)
  • Table 4 U.S. Gastrointestinal Surgery Procedures Market, by Indication, 2021 - 2033 (USD Billion)
  • Table 5 U.S. Gastrointestinal Surgery Procedures market, by Procedure Urgency, 2021 - 2033 (USD Billion)
  • Table 6 U.S. Gastrointestinal Surgery Procedures market, by End Use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 U.S. gastrointestinal surgery procedures market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 CPT & indication outlook (USD Billion)
  • Fig. 10 Procedure urgency & end use outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 U.S. gastrointestinal surgery procedures market dynamics
  • Fig. 13 U.S. gastrointestinal surgery procedures market: Porter's five forces analysis
  • Fig. 14 U.S. gastrointestinal surgery procedures market: PESTLE analysis
  • Fig. 15 U.S. gastrointestinal surgery procedures market: CPT segment dashboard
  • Fig. 16 U.S. gastrointestinal surgery procedures market: CPT market share analysis, 2025 & 2033
  • Fig. 17 43020-43135, 43279-43499 market, 2021 - 2033 (USD Billion)
  • Fig. 18 44005-44346, 44500-44799, 44800-44899, 44900-44979, 45000-45190, 45395-45999, 46020-46505, 46700-46999 market, 2021 - 2033 (USD Billion)
  • Fig. 19 47010-47399, 47400-47480, 47562-47999, 48020, 48105-48160, 48500-48999 market, 2021 - 2033 (USD Billion)
  • Fig. 20 43644-43645; 43770-43775; 43845-43848; 43886-43888 market, 2021 - 2033 (USD Billion)
  • Fig. 21 U.S. gastrointestinal surgery procedures market: Indication segment dashboard
  • Fig. 22 U.S. gastrointestinal surgery procedures market: Indication market share analysis, 2025 & 2033
  • Fig. 23 Cancer market, 2021 - 2033 (USD Billion)
  • Fig. 24 Benign GI disorders market, 2021 - 2033 (USD Billion)
  • Fig. 25 Acute/emergency conditions market, 2021 - 2033 (USD Billion)
  • Fig. 26 Obesity market, 2021 - 2033 (USD Billion)
  • Fig. 27 Other conditions market, 2021 - 2033 (USD Billion)
  • Fig. 28 U.S. gastrointestinal surgery procedures market: Procedure urgency segment dashboard
  • Fig. 29 U.S. gastrointestinal surgery procedures market: Procedure urgency market share analysis, 2025 & 2033
  • Fig. 30 Elective market, 2021 - 2033 (USD Billion)
  • Fig. 31 Urgent market, 2021 - 2033 (USD Billion)
  • Fig. 32 Emergency market, 2021 - 2033 (USD Billion)
  • Fig. 33 U.S. gastrointestinal surgery procedures market: End use segment dashboard
  • Fig. 34 U.S. gastrointestinal surgery procedures market: End use market share analysis, 2025 & 2033
  • Fig. 35 Hospitals market, 2021 - 2033 (USD Billion)
  • Fig. 36 Ambulatory surgical centers market, 2021 - 2033 (USD Billion)
  • Fig. 37 Specialty surgical centers market, 2021 - 2033 (USD Billion)
  • Fig. 38 Other market, 2021 - 2033 (USD Billion)
  • Fig. 39 Company categorization
  • Fig. 40 Company market position analysis
  • Fig. 41 Strategic framework